New Straits Times reports Malaysia's healthcare-travel revenue reached RM3.35 billion in 2025, up 23.2% from RM2.72 billion, on 1.85 million medical travellers (+15.6%) — roughly double the sector's pre-pandemic revenue. With the Malaysia Year of Medical Tourism 2026 campaign running, revenue growing faster than volume means higher-value patients staying longer, with companions — a hotel demand stream most underwriting still ignores.
New Straits Times reported in May that Malaysia's medical-tourism revenue climbed 23.2% to RM3.35 billion in 2025, from RM2.72 billion in 2024, while medical travellers rose 15.6% to 1.85 million. Against 2019 — RM1.7 billion and 1.22 million patients — revenue has roughly doubled on about half again as many patients.
The hotel demand hiding in the health data
Medical travellers are a hotel underwriter's favourite kind of guest, rarely underwritten: they book longer stays, travel with companions, are price-insensitive relative to leisure demand, and arrive year-round rather than seasonally. Higher-value procedures — the segment now driving the growth — extend recovery stays further. The Malaysia Year of Medical Tourism 2026 campaign explicitly targets integrated healthcare-hospitality packages.
A BMI analyst quoted in the report puts Malaysia's edge on 'affordability, quality healthcare and cultural familiarity' for Middle Eastern, South Asian and Asean patients — source markets served through KL's connectivity and, for the Singapore-adjacent segment, through Johor.
Key takeaways
- Record RM3.35 billion healthcare-travel revenue in 2025, up 23.2%; 1.85 million travellers, up 15.6%.
- Revenue is growing faster than patient volume — Malaysia is capturing higher-value, longer-stay procedures.
- MYMT 2026 is actively packaging healthcare with hospitality — a direct policy tailwind for hotel demand.
- Medical demand is year-round and companion-heavy: a stabiliser for occupancy underwriting, not a bonus line.
Why this matters to hotel investors
This is a fast-compounding, officially measured demand stream that most Malaysian hotel underwriting still leaves out. Investors who count it are pricing demand their competitors are missing.
What we checked
Claims independently checked
- The 2025 revenue (RM3.35 billion, +23.2%) and traveller (1.85 million, +15.6%) figures are consistent with NST's July 2026 medical-tourism-ranking coverage already cited on this site (src-nst-medical-tourism).
- Accessed via KLSE Screener's syndication of the NST piece, as nst.com.my blocked automated access on the access date.
Claims not independently verified
- Sector figures originate from the Malaysia Healthcare Travel Council; the desk has not audited the underlying counting methodology.
- The analyst's competitive-positioning view is expert opinion, not measured market share.
These figures are reported as the original publisher's (or the named party's) claims. Treat them as claims, not as independently established facts.
Sources
Each source is labelled with how far it can be relied on. We do not present promotional material as independently verified, and we say so when we could not check something.
New Straits Times (via KLSE Screener syndication)
“Malaysia to gain more ground in medical tourism”
NST report (accessed via KLSE Screener's syndication, as nst.com.my blocked automated access): healthcare-travel revenue RM3.35 billion in 2025 (+23.2% from RM2.72 billion), 1.85 million medical travellers (+15.6%), roughly double 2019's RM1.7 billion, with MHTC and an analyst quoted.
News publication · Published 18 May 2026 · Accessed 20 Jul 2026
High credibility“Malaysia ranked world's 6th-best medical tourism destination, led by Penang”
English-language corroboration of the medical-tourism ranking: Malaysia sixth globally, Penang contributing roughly 45% of national medical-tourism revenue, and sector revenue of RM3.35 billion in 2025, up 23.2% year on year.
News publication · Published 7 Jul 2026 · Accessed 17 Jul 2026
High credibility
The information published on this platform is for general educational and market-intelligence purposes only. It does not constitute financial, legal, tax, property, or investment advice. Readers should conduct independent due diligence and seek advice from qualified professionals before making any investment decision.
